These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 22010613)

  • 21. Multimodal techniques for smoking cessation: a review of their efficacy and utilisation and clinical practice guidelines.
    Reus VI; Smith BJ
    Int J Clin Pract; 2008 Nov; 62(11):1753-68. PubMed ID: 18795968
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Drug treatment of tobacco dependence].
    Friederich HM; Batra A
    Dtsch Med Wochenschr; 2009 Nov; 134(47):2402-5. PubMed ID: 19911331
    [No Abstract]   [Full Text] [Related]  

  • 23. A new medication for the worst addiction.
    O'Brien CP
    Curr Psychiatry Rep; 2007 Oct; 9(5):345-6. PubMed ID: 17915070
    [No Abstract]   [Full Text] [Related]  

  • 24. Understanding statistical hypothesis testing.
    Sedgwick P
    BMJ; 2014 May; 348():g3557. PubMed ID: 24879817
    [No Abstract]   [Full Text] [Related]  

  • 25. A feasibility study of varenicline for smoking cessation in bipolar patients with subsyndromal depression.
    Frye MA; Ebbert JO; Prince CA; Lineberry TW; Geske JR; Patten CA
    J Clin Psychopharmacol; 2013 Dec; 33(6):821-3. PubMed ID: 23963060
    [No Abstract]   [Full Text] [Related]  

  • 26. Molecule of the Month. Varenicline tartrate.
    Drug News Perspect; 2006 Apr; 19(3):162. PubMed ID: 16804568
    [No Abstract]   [Full Text] [Related]  

  • 27. In brief: Cardiovascular safety of varenicline (Chantix).
    Med Lett Drugs Ther; 2011 Aug; 53(1371):65. PubMed ID: 21860367
    [No Abstract]   [Full Text] [Related]  

  • 28. Cost-effectiveness of varenicline for smoking cessation.
    Keiding H
    Expert Rev Pharmacoecon Outcomes Res; 2009 Jun; 9(3):215-21. PubMed ID: 19527093
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Varenicline: a selective alpha4beta2 nicotinic acetylcholine receptor partial agonist approved for smoking cessation.
    Lam S; Patel PN
    Cardiol Rev; 2007; 15(3):154-61. PubMed ID: 17438382
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Varenicline.
    Niaura R; Jones C; Kirkpatrick P
    Nat Rev Drug Discov; 2006 Jul; 5(7):537-8. PubMed ID: 16883648
    [No Abstract]   [Full Text] [Related]  

  • 31. Smoking cessation with varenicline, a selective alpha4beta2 nicotinic receptor partial agonist: results from a 7-week, randomized, placebo- and bupropion-controlled trial with 1-year follow-up.
    Nides M; Oncken C; Gonzales D; Rennard S; Watsky EJ; Anziano R; Reeves KR
    Arch Intern Med; 2006 Aug 14-28; 166(15):1561-8. PubMed ID: 16908788
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and safety of the novel selective nicotinic acetylcholine receptor partial agonist, varenicline, for smoking cessation.
    Oncken C; Gonzales D; Nides M; Rennard S; Watsky E; Billing CB; Anziano R; Reeves K
    Arch Intern Med; 2006 Aug 14-28; 166(15):1571-7. PubMed ID: 16908789
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Utilization of the smoking cessation medicine varenicline: an intensive post-marketing study in New Zealand.
    Harrison-Woolrych M; Ashton J
    Pharmacoepidemiol Drug Saf; 2010 Sep; 19(9):949-53. PubMed ID: 20602347
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Medications for smoking cessation. New advice concerning important neuropsychiatric effects].
    Sabourin G
    Perspect Infirm; 2010; 7(1):55. PubMed ID: 20120183
    [No Abstract]   [Full Text] [Related]  

  • 35. [New tobacco dependence drug: Varenicline, partial agonist of alpha4beta2 acetylcholine-nicotine receptors].
    Králíková E
    Cas Lek Cesk; 2006; 145(11):832-4. PubMed ID: 17168413
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New weapon to curb smoking: no more excuses to delay treatment.
    Johnson BA
    Arch Intern Med; 2006 Aug 14-28; 166(15):1547-50. PubMed ID: 16908786
    [No Abstract]   [Full Text] [Related]  

  • 37. Update on smoking cessation therapies.
    Glynn DA; Cryan JF; Kent P; Flynn RA; Kennedy MP
    Adv Ther; 2009 Apr; 26(4):369-82. PubMed ID: 19399385
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Varenicline in smoking cessation.
    Tonstad S; Rollema H
    Expert Rev Respir Med; 2010 Jun; 4(3):291-9. PubMed ID: 20524911
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Varenicline for smoking reduction prior to cessation.
    Cropsey KL; Clark CB; Hendricks PS
    JAMA; 2015 Jun; 313(22):2284-5. PubMed ID: 26057292
    [No Abstract]   [Full Text] [Related]  

  • 40. Varenicline for smoking reduction prior to cessation.
    Robey RB; Block CA; O'Rourke DJ
    JAMA; 2015 Jun; 313(22):2285. PubMed ID: 26057293
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.